Suppr超能文献

5-氨基酮戊酸光动力疗法是治疗女性难治性外阴硬化性苔藓的一种安全有效的方法。

5-Aminolevulinic acid photodynamic therapy is a safe and effective treatment for female patients with intractable vulvar lichen sclerosus.

机构信息

Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China; School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, China.

Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, China; Key Laboratory of Gynecologic Oncology of Shandong Province, China.

出版信息

Photodiagnosis Photodyn Ther. 2024 Oct;49:104330. doi: 10.1016/j.pdpdt.2024.104330. Epub 2024 Sep 7.

Abstract

BACKGROUND

Female vulvar lichen sclerosus (VLS) is a chronic inflammatory skin disease of the vulva and its etiology is unknown. The main clinical symptoms are itching, burning and dyspareunia, and there is a lack of effective treatment.

METHODS

Clinical and follow-up data of women with VLS who underwent 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) from January 2023 to December 2023 in the department of obstetrics and gynecology, Qilu Hospital of Shandong University, were retrospectively analyzed. According to the inclusion and exclusion criteria, 36 patients with VLS who received ineffective conventional treatment (intractable VLS) were enrolled. Objective signs and subjective symptoms of vulvar lesions were recorded before treatment and 6 months after the end of treatment according to corresponding scoring criteria. Quality of life was evaluated using the Dermatology Life Quality Index (DLQI).

RESULTS

All patients received six sessions of ALA-PDT treatment and follow-up visits. After ALA-PDT treatment, 24 of 36 (66.67 %) patients' itching symptoms completely disappeared, 10 of 36 (27.78 %) patients' itching symptoms were relieved from severe to mild, and only 2 of 36 (5.56 %) patients' symptoms were not significantly relieved. 16 of 36 (44.4 %) patients' itching symptoms completely disappeared, 9 of 36 (25 %) patients' itching symptoms were relieved from severe to mild, and only 2 of 36 (5.56 %) patients still had severe pain. Compared to 22 patients with dyspareunia before treatment, only 9 patients still had dyspareunia with varying degrees of dyspareunia relief after treatment. Clinical signs improved significantly in the patients after ALA-PDT treatment. The total scores of clinical signs were (5.31 ± 1.67 vs 3.67 ± 1.71) before and after treatment. All patients showed improvement in DLQI after treatment. The main side effects of ALA-PDT were pain, erythema and swelling which were transient and tolerable. All patients were "satisfied" or "very satisfied" with the results of the treatment.

CONCLUSIONS

ALA-PDT is a safe and effective treatment for women with intractable vulva lichen sclerosus.

摘要

背景

女性外阴硬化性苔藓(VLS)是一种外阴慢性炎症性皮肤病,其病因不明。主要的临床症状是瘙痒、灼热和性交困难,且缺乏有效的治疗方法。

方法

回顾性分析 2023 年 1 月至 2023 年 12 月在山东大学齐鲁医院妇产科行 5-氨基酮戊酸光动力疗法(ALA-PDT)治疗的 VLS 女性患者的临床和随访资料。根据纳入和排除标准,共纳入 36 例常规治疗无效的 VLS 患者(难治性 VLS)。根据相应的评分标准,在治疗前和治疗结束后 6 个月记录外阴病变的客观体征和主观症状。采用皮肤病生活质量指数(DLQI)评估生活质量。

结果

所有患者均接受 6 次 ALA-PDT 治疗和随访。ALA-PDT 治疗后,36 例患者中 24 例(66.67%)瘙痒症状完全消失,10 例(27.78%)瘙痒症状由重度缓解为轻度,仅 2 例(5.56%)症状无明显缓解。36 例患者中 16 例(44.44%)瘙痒症状完全消失,9 例(25%)瘙痒症状由重度缓解为轻度,仅 2 例(5.56%)仍有重度疼痛。与治疗前 22 例性交困难的患者相比,治疗后仅 9 例仍有不同程度性交困难,性交困难缓解。ALA-PDT 治疗后患者的临床体征明显改善。治疗前后的临床体征总评分分别为(5.31±1.67)分和(3.67±1.71)分。所有患者治疗后 DLQI 均有改善。ALA-PDT 的主要不良反应为疼痛、红斑和肿胀,均为短暂且可耐受。所有患者对治疗结果均“满意”或“非常满意”。

结论

ALA-PDT 是治疗难治性外阴硬化性苔藓女性患者的一种安全有效的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验